Regulatory authorities are responsible for overseeing medical products and are
tasked with the prevention, detection, and response to substandard and falsified
medical products. Ministries of health and other stakeholders that are involved
in procurement of medical products, such as non-governmental organizations,
academia, and procurement agencies, play equally crucial roles, alongside
regulatory authorities, in implementing interventions to address substandard and
falsified medical products.